Bristol-Myers Squibb Co., with research operations in Wallingford, said Monday it signed contracts with clinical development services companies Parexel International Corp. and Icon to help it with its drug development program, The Associated Press reports.
Bristol-Myers did not disclose financial terms of the contracts, but said the deals will support development of the company’s pipeline over the next three years.
